Metraipolis › archive › dc_bbbe8de2244f

Real-World Effectiveness of Nirsevimab in Preventing RSV Hospitalizations: Evidence of Protection in Southern Italian Infants, 2024-2025 — Europe PMC PMID:41165546

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41165546
DOI
10.1002/jmv.70662
License (as archived)
solo-consultazione
Archived
2026-11-08T20:40:04.604Z
SHA-256 of the archived text
6ef69701f98f281d1f664c489cd7af1d1e2296b972275bfe66026b6bdc92ff38
Stable URL of this page
https://metraipolis.com/documento/dc_bbbe8de2244f

How to cite

Real-World Effectiveness of Nirsevimab in Preventing RSV Hospitalizations: Evidence of Protection in Southern Italian Infants, 2024-2025 — Europe PMC PMID:41165546 — Europe PMC (en), https://europepmc.org/article/MED/41165546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbbe8de2244f (Metraipolis archive dc_bbbe8de2244f, sha256 6ef69701f98f281d1f664c489cd7af1d1e2296b972275bfe66026b6bdc92ff38)
BibTeX
@misc{dcbbbe8de2244f,
  title = {Real-World Effectiveness of Nirsevimab in Preventing RSV Hospitalizations: Evidence of Protection in Southern Italian Infants, 2024-2025 — Europe PMC PMID:41165546},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41165546},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbbe8de2244f; sha256 6ef69701f98f281d1f664c489cd7af1d1e2296b972275bfe66026b6bdc92ff38},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41165546. Agents can read the archived copy with the MCP tool read_document.